Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ramucirumab
Drug ID BADD_D01911
Description Ramucirumab is a human monoclonal antibody (IgG1) against vascular endothelial growth factor receptor 2 (VEGFR2), a type II trans-membrane tyrosine kinase receptor expressed on endothelial cells. By binding to VEGFR2, ramucirumab prevents binding of its ligands (VEGF-A, VEGF-C, and VEGF-D), thereby preventing VEGF-stimulated receptor phosphorylation and downstream ligand-induced proliferation, permeability, and migration of human endothelial cells. VEGFR stimulation also mediates downstream signalling required for angiogenesis and is postulated to be heavily involved in cancer progression, making it a highly likely drug target. In contrast to other agents directed against VEGFR-2, ramucirumab binds a specific epitope on the extracellular domain of VEGFR-2, thereby blocking all VEGF ligands from binding to it. Ramucirumab is indicated for us in advanced gastric or gastro-esophageal junction adenocarcinoma as a single agent or in combination with paclitaxel after prior fluoropyrimidine- or platinum-containing chemotherapy.
Indications and Usage For use in advanced gastric or gastro-esophageal junction adenocarcinoma as a single agent or in combination with paclitaxel after prior fluoropyrimidine- or platinum-containing chemotherapy.
Marketing Status approved; investigational
ATC Code L01FG02
DrugBank ID DB05578
KEGG ID D09371
MeSH ID C543333
PubChem ID Not Available
TTD Drug ID D09HVD
NDC Product Code 0002-2129; 63419-0535; 0002-7669; 0002-7678; 0002-2477; 73424-0329
UNII D99YVK4L0X
Synonyms ramucirumab | LY3009806 | Cyramza | IMC 1121B | IMC1121B | IMC-1121B | 1121B
Chemical Information
Molecular Formula Not Available
CAS Registry Number 947687-13-0
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Thrombocytopenia01.08.01.002---
Thyroid disorder05.02.01.002---
Infusion related reaction08.01.03.002; 10.01.01.017; 12.02.05.009--
Haemorrhage24.07.01.002---
Embolism24.01.01.009--
Antibody test positive13.06.03.001---
Decreased appetite08.01.09.028; 14.03.01.005--
Posterior reversible encephalopathy syndrome17.13.02.007--
Red blood cell transfusion25.06.01.006---
The 2th Page    First    Pre   2    Total 2 Pages